The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 2014 Genitourinary Cancers Symposium

Cardiovascular Risk with ADT for Advanced Prostate Cancer

San Francisco, California / January 30-February 1, 2014

San Francisco - The principal goal of androgen deprivation therapy (ADT) is to reduce testosterone to castrate levels, thereby depriving prostate cancer cells of their key growth substrate. However, several studies have shown that ADT...

PRIORITY PRESS - 55th Annual Meeting of the American Society of Hematology (ASH)

Strategies for Control of Multiple Myeloma Refined By New and Extended Data Analysis of Major Trials

New Orleans, Louisiana / December 7-10, 2013

New Orleans - Of data with practice-changing implications for control of multiple myeloma presented at ASH 2013, the most significant involved dosing of front-line therapy in those who are transplant-ineligible. In this group, it was shown...

PRIORITY PRESS - 36th Annual San Antonio Breast Cancer Symposium (SABCS)

Advances in Endocrine Therapy for Breast Cancer

San Antonio, Texas / December 10-14, 2013

San Antonio - Endocrine therapy is an important weapon in a clinician’s armamentarium against metastatic breast cancer (mBC). Several endocrine therapies are considered standard for hormone receptor-positive (HR+) postmenopausal...

PRIORITY PRESS - ECCO-17 - 38th ESMO Multidisciplinary Congress

Improving the Journey for Men with Metastatic Castrate Resistant Prostate Cancer

Amsterdam, The Netherlands / September 27-October 1, 2013

Amsterdam - Prostate cancer (PC) remains the most commonly diagnosed cancer in males and it is the second leading cause of death in men. Skeletal complication is the most important morbidity point in terms of metastases in PC and almost all...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the ECCO-17 - 38th ESMO Multidisciplinary Congress

LHRH Agonism vs. LHRH Antagonism: Cardiovascular Disease Difference Now Documented in Large Pooled Analysis

Amsterdam, The Netherlands / September 27-October 1, 2013

Guest Editor: Dr. Pierre I. Karakiewicz, MDUrologic Oncologist,      Associate Professor and Senior Outcomes Research ScientistDirector, Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health...

PRIORITY PRESS - ECCO-17 - 38th ESMO Multidisciplinary Congress

Targeted Therapies in Metastatic GIST and CRC

Amsterdam, The Netherlands / September 27-October 1, 2013

Amsterdam - Gastrointestinal stromal tumors (GIST) are a rare but treatable soft tissue sarcoma. Unlike other gastrointestinal cancers, more than 85% of GISTs express the KIT oncogene. Treatments that target the tyrosine kinase activity of...

PRIORITY PRESS - 8th World Congress of Melanoma

New Advances in the Treatment of Basal Cell Carcinoma: Targeting the Hedgehog Signaling Pathway

Hamburg, Germany / July 17-20, 2013

Hamburg - Until recently, treatment options for advanced basal cell carcinoma (BCC) were limited and suboptimal. Research into novel therapeutic targets identified mutations in the hedgehog signaling pathway as a possible cause of new...

PHYSICIAN PERSPECTIVE - Viewpoint based on literature: Rummel et al. Lancet 2013;381(9873):1203-10.

Therapies for Indolent Lymphomas: Progress in Efficacy and Tolerability

May 2013

Reviewed and Edited by: Laurie H. Sehn, MD, MPHClinical Associate ProfessorBC Cancer Agency andThe University of British ColumbiaVancouver, British Columbia   Introduction Consensus about the optimal first-line approach to indolent...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 108th Annual Meeting of the American Urological Association

New Oral Oncolytics: Major Step Forward in the Management of Metastatic Castrate-Resistant Prostate Cancer

San Diego, California / May 4-8, 2013

Reviewed and edited by:  Fred Saad, MD, FRCSProfessor and Chief of Urology Director of Urologic OncologyU of M Endowed Chair in Prostate CancerUniversity of Montreal Hospital CentreUniversité de MontréalMontreal,...

PAGE 2 OF 23   1 2 3 4 5 6 7 8 9 10 ...